Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Eugit Therapeutics logo — Tissue targeting of therapies

Eugit Therapeutics

Tissue targeting of therapies

Founded 2022 United States San Carlos, United States 2 employees Seed Total: $130.00K Biotechnology, Health Care +1

General Information

Company Name Eugit Therapeutics
Founded Year 2022
Location United States San Carlos, United States +1
Employees 2
Industries Biotechnology, Health Care, Health and Wellness
Funding Stage Seed
Social

Get notified when Eugit Therapeutics moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Eugit Therapeutics

Eugit Therapeutics, with its compelling slogan "Tissue targeting of therapies," emerges as an innovative player in the Biotechnology sector. Established in 2022 and based in the United States, this startup is cofounded by renowned academic George Church of Harvard. Their prominent backing includes Y Combinator, part of their S22 cohort, and a significant NSF Ph1 grant.

Positioned at the intersection of Health Care and Wellness, Eugit Therapeutics secured a $130.00K Seed investment on 01 September 2022, highlighting their potential for growth and innovation within their field.

With experienced leadership and strategic partnerships, Eugit Therapeutics presents a strong case for investors interested in cutting-edge biotech advancements. Their targeted approach to therapy delivery holds promise for significant impacts in healthcare.

Taxonomy: Tissue Targeting Therapies, Immune System, Drug Discovery, Immune-Mediated Diseases, Inflammatory Bowel Disease, IBD, Gamma Delta T Cells, Precision Medicine, Therapeutic Development, Biomedical Innovation, Harvard Co-Founded, Y Combinator Backed, NSF Funded, George Church

Services & Products

Development of tissue targeting therapies
Research in computational genomics and immunology
Disease and functional immunology research

Target Customers

Biotech and pharmaceutical companies Research institutions Healthcare providers

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Seed •••••• 1
Investor
01 Sep 2022
Support Program •••••• 1
Investor
01 Jun 2022

Eugit Therapeutics Alternatives & Competitors

View All Alternatives
Eugit Therapeutics vs
Nuvig Therapeutics Inc.
Nuvig Therapeutics Inc. United States

Rebalancing Immune Function for Chronic Inflammatory and Autoimmune Diseases

Series A
24 employees
Biotechnology, Health Care
Eugit Therapeutics vs
Georgiamune Inc.
Georgiamune Inc. United States

Georgiamune is reprogramming immune signaling pathways to redirect the immune system to fight diseas...

Series A
30 employees
Biotechnology, Health Care
Eugit Therapeutics vs
ImmunoGenesis, Inc.
ImmunoGenesis, Inc. United States

Re-envisioning cold tumor treatment. Our deliberate drug development strategy targets mechanisms of...

Series Unknown
14 employees
Biotechnology, Health Care
View all alternatives

FAQ About Eugit Therapeutics

Tissue targeting of therapies
Eugit Therapeutics was founded in 2022.
Eugit Therapeutics is headquartered in San Carlos, United States.
Eugit Therapeutics operates in the following industries: Biotechnology, Health Care, Health and Wellness.
Eugit Therapeutics has approximately 2 employees.
Eugit Therapeutics has completed 2 funding rounds, raising a total of $130.00K. The latest funding stage is Seed.
Eugit Therapeutics offers: Development of tissue targeting therapies, Research in computational genomics and immunology, Disease and functional immunology research.
Top alternatives and competitors to Eugit Therapeutics include Nuvig Therapeutics Inc., Georgiamune Inc., ImmunoGenesis, Inc., Inflazome, SQZ Biotechnologies. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Eugit Therapeutics and Nuvig Therapeutics Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Eugit Therapeutics and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy